Training and Testing Database for IMU Based Gait Analysis Methods
NCT ID: NCT07236008
Last Updated: 2025-11-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
150 participants
OBSERVATIONAL
2025-12-01
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
By achieving these objectives, the study aims to improve the accuracy of GE detection from wearable sensors and enable more accessible, scalable, and reliable gait analysis outside the laboratory environment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Technical Evaluation of Commercial IMUs Within Clinical Gait Analysis
NCT05751408
Assessment of Accelerometric Measurement Devices for Gait Analysis
NCT01522690
Interlaboratory Reliability of 3D Gait Analysis
NCT05530213
The Use of Artificial Intelligence (AI) for Gait Analysis
NCT06289231
Normative Database for Gait Analysis on the GRAIL UZ Gent
NCT04987346
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy subjects
Age 18-65 years old
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No history of pain in the lower limbs in the past 6 months.
* No history of lower limbs injuries/surgeries in the past 6 months.
* Language: Dutch and/or English and/or French speakers.
* Age 18-65 years old
* Subjects must be able to understand the instructions and to answer questions. Additionally, they should be able to; signal pain, fear, discomfort; give inform consent.
Exclusion Criteria
* Individuals with metal implants or skin conditions that would make sensor or marker placement difficult.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vrije Universiteit Brussel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bart Jansen
Prof.Dr.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
25235
Identifier Type: REGISTRY
Identifier Source: secondary_id
25235_IMU-GAIT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.